The COVID-19 landscape has continued to evolve during the 2 years since it was first detected in the United States, and research continues to explore how both the virus and its multiple vaccines affect people in different populations.
Individuals with psoriasis or psoriatic arthritis often also have comorbidities that increase negative outcomes of COVID-19, reinforcing the importance of vaccination for this population. However, vaccine hesitancy continues to be an issue that clinicians should be aware of and focus on when counseling psoriatic disease patients.
While the risk of contracting
Vaccines remain main aspect to COVID-19’s evolving landscape
The COVID-19 landscape has continued to evolve during the 2 years since it was first detected in the United States, and research continues to explore how both the virus and its multiple vaccines affect people in different populations.
Individuals with psoriasis or psoriatic arthritis often also have comorbidities that increase negative outcomes of COVID-19, reinforcing the importance of vaccination for this population. However, vaccine hesitancy continues to be an issue that clinicians should be aware of and focus on when counseling psoriatic disease patients.
While the risk of contracting